Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
MaxCyte Inc
MXCTCurrent price
279 GBX
-14.93 GBX (-5.10%)
Last closed
3.88 USD
Company
maxcyte.com
ISIN
US57777K1060
Sector
Healthcare
Industry
Medical Devices
Exchange
London Exchange
Capitalization
396 185 536 USD
Yield for 12 month
+3.28 %
1Y
3Y
5Y
10Y
15Y
MXCT
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland. Address: 9713 Key West Avenue, Rockville, MD, United States, 20850
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.25 USDP/E ratio
–Dividend Yield
–Current Year
+41 288 000 USD
Last Year
+44 261 500 USD
Current Quarter
+10 429 000 USD
Last Quarter
+11 342 000 USD
Current Year
+32 561 000 USD
Last Year
+39 163 100 USD
Current Quarter
+7 907 000 USD
Last Quarter
+8 871 000 USD
Key Figures MXCT
1 year
3 years
5 years
10 years
EBITDA
-41 916 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-11.07 %
PEG Ratio
–
Return On Equity TTM
-15.33 %
Wall Street Target Price
9.25 USD
Revenue TTM
45 439 000 USD
Book Value
2.11 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
15.3 %
Dividend Yield
–
Gross Profit TTM
39 163 100 USD
Earnings per share
-0.34 USD
Diluted Eps TTM
-0.34 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-77.97 %
Dividend Analytics MXCT
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MXCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MXCT
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
5.3864
Price Sales TTM
8.7191
Enterprise Value EBITDA
-11.0737
Price Book MRQ
1.7906
Financials MXCT
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MXCT
For 52 weeks
3.15 USD
5.55 USD
50 Day MA
3.9 USD
Shares Short Prior Month
3 852 910
200 Day MA
4.28 USD
Short Ratio
10.27
Shares Short
3 508 938
Short Percent
3.37 %
BeatStart